Publications:

Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model.

British Journal Of Pharmacology

Takashima, K K; Matsunaga, N N; Yoshimatsu, M M; Hazeki, K K; Kaisho, T T; Uekata, M M; Hazeki, O O; Akira, S S; Iizawa, Y Y; Ii, M M

Publication Date: 2009-08

Variant appearance in text: TLR4: C747A

PubMed Link: 19563534

Variant Present in the following documents:

• Main text

View BVdb publication page